Methyl (1S,3S and 1R,3S)-1-(2,2-dimethoxyethyl)1,2,3,4-tetrahydrocarboline-
3-carboxylate (3) was hydrolyzed in the presence of sodium hydroxide to giv
e (1S,3S and 1R, 3S)-1-(2,2-dimethoxyethyl)- 1,2,3,4-tetrahydrocarboline-3-
carboxylic acid (4) which was reduced with LiAlH4 to provide (1S,3S)- and (
1R,3S)-1-(2,2-dimethoxyethyl)-3-hydroxymethyl-1,2,3,4-tetrahydrocarboline (
10) and then amidated in ammonia containing methanol to obtain (1S,3S)and (
1R,3S)-1-(2,2-dimethoxyethyl)- 1,2,3,4-tetrahydrocarboline-3-carboxamide (1
4). Acylation of (1S,3S and 1R,3S)-3, (1S,3S and 1R,3S)-4, (1S,3S)-10, (1R,
3S)-10, (1S,3S)-14 and (1R,3S)-14 afforded the corresponding methyl (1S,3S
and 1R, 3S)-1-(2,2-dimethoxyethyl)-2-(1,3-dioxobutyl)-1,2,3,4-tetrahydrocar
bolines-3-carboxylate (6), (IS,3S and 1R,3S)-1(2,2-dimethoxyethyl) -2-(1,3-
dioxobutyl)-1,2,3,4-tetrahydrocarboline-3-carboxylic acid (5), (1S,3S)- and
(1R,3S)-1-(2,2-dimethoxyethyl)-2-(1,3-dioxobutyl)-3-(1,3-dioxobutyl)oxymet
hyl-1,2,3,4-tetrahydrocarboline (11), (1S,3S)- and (1R,3S)-1-(2,2-dimethoxy
ethyl)-2-(1,3-dioxobutyl)-1,2,3,4,-tetrahydrocarboline-3-carboxamide (15),
respectively. After Aldol reaction, dehydration and dehydrogenation the des
ired (6S)-6-substituted 4,6,7,12-tetrahydro-4-oxoindolo [2,3-a]quinolizines
8, 9, 12, 13, and 16 were obtained. Their anticancer activities in vitro w
ere investigated.